title: Uncoupling of the order of the S and M phases: effects of staurosporine on human cell cycle kinases.
abstract: The protein kinase inhibitor staurosporine (SSP) was employed to study the involvement of kinases in human cell cycle progression. Thirty to 100 ng/ml SSP blocks entry into S phase and M phase. Lack of entry into S phase is due to impaired activity of the retinoblastoma protein kinase. The requirement for any of the SSP-sensitive kinases for cell cycle progression can be abrogated in tumour cells. Therefore, these kinases act in a checkpoint network negatively controlling the initiation of S phase, M phase and cytokinesis, rather than being inherent parts of a substrate-product chain required for the initiation of the cell cycle phases. As a consequence of the lack of certain checkpoint effectors, tumour cells may endoreduplicate or binucleate in the presence of SSP. The latter processes, as well as meiosis, are naturally occurring in specialized cell types, leading to the idea that this checkpoint network controls the order of the cell cycle phases in normal cells. A model is presented where the cell cycle is envisioned as two independently running cycles, the S and the M cycle, which are controlled by intra and intercycledependent checkpoints in human somatic cells. The model accounts for the dependency of S and M phase initiation on the successful completion of the previous M and S phase, respectively, as well as entry into a resting state.
authors.affiliation: Department of Biophysics, Norwegian Radium Hospital, Montebello, Oslo, Norway.
authors.forename: T
authors.initials: T
authors.lastname: Stokke
authors.forename: L
authors.initials: L
authors.lastname: Smedshammer
authors.forename: T S
authors.initials: TS
authors.lastname: Jonassen
authors.forename: H K
authors.initials: HK
authors.lastname: Blomhoff
authors.forename: K
authors.initials: K
authors.lastname: Skarstad
authors.forename: H B
authors.initials: HB
authors.lastname: Steen
mesh_terms: D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000032:analysis / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology*; D016158:Genes, p53; D006801:Humans; D008540:Meiosis; D008938:Mitosis / Q000187:drug effects; D008954:Models, Biological; D009369:Neoplasms / Q000378:metabolism; D011123:Polyploidy; D011494:Protein Kinases / Q000378:metabolism*; D012175:Retinoblastoma / Q000201:enzymology; D016160:Retinoblastoma Protein / Q000235:genetics / Q000378:metabolism; D016196:S Phase / Q000187:drug effects; D019311:Staurosporine / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D016160:Retinoblastoma Protein; D004247:DNA; D011494:Protein Kinases; D019311:Staurosporine